SCHEMBL16811486

SCHEMBL16811486

c1ccc(-c2cc(-c3cccc4oc5ccccc5c34)nc(-n3c4ccccc4c4cc5oc6ccccc6c5cc43)n2)cc1

nearest known ligand 0.33

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
▸ CYP1A2 P05177 2/20 0.33
▸ MAPT P10636 2/20 0.33
▸ CYP2C9 P11712 2/20 0.33
▸ CYP2C19 P33261 2/20 0.33
▸ SMN1; SMN2 Q16637 2/20 0.33
▸ KMT2A Q03164 2/20 0.33
▸ MEN1 O00255 1/20 0.33
▸ LMNA P02545 1/20 0.33
▸ MAPK10 P53779 1/20 0.33
▸ TDP1 Q9NUW8 1/20 0.33
▸ AHR P35869 1/20 0.32
▸ GAA P10253 2/20 0.31
▸ CYP3A4 P08684 1/20 0.31
▸ AGTR1 P30556 1/20 0.31
▸ NPSR1 Q6W5P4 1/20 0.31
▸ MAPK1 P28482 1/20 0.31
▸ KDM4E B2RXH2 1/20 0.30
▸ ALDH1A1 P00352 1/20 0.30
▸ HPGD P15428 1/20 0.30
▸ HSD17B10 Q99714 1/20 0.30

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL16185484 0.92 MAPT (0.37) CYP1A2MAPTCYP2C9CYP2C19SMN1; SMN2
SCHEMBL19769831 0.92 KDM4E (0.38) CYP1A2MAPTCYP2C9CYP2C19SMN1; SMN2
SCHEMBL24848885 0.92 MAPT (0.34) CYP1A2MAPTCYP2C9CYP2C19SMN1; SMN2
SCHEMBL2603665 0.91 AHR (0.37) MAPTSMN1; SMN2KMT2AMEN1LMNA
SCHEMBL16810921 0.91 ALOX5 (0.37) CYP1A2MAPTCYP2C9CYP2C19SMN1; SMN2
SCHEMBL16811634 0.90 BRDT (0.31) —
SCHEMBL16811007 0.89 ALOX5 (0.38) CYP1A2MAPTCYP2C9CYP2C19SMN1; SMN2
SCHEMBL19769726 0.89 KDM4E (0.37) CYP1A2MAPTCYP2C9CYP2C19SMN1; SMN2
SCHEMBL19239476 0.88 PLA2G2A (0.34) CYP1A2MAPTCYP2C9CYP2C19SMN1; SMN2
SCHEMBL17071026 0.88 AHR (0.35) CYP1A2MAPTSMN1; SMN2KMT2AMEN1

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 6 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-20210226134-A1 CONDENSED CYCLIC COMPOUND AND ORGANIC LIGHT-EMITTING DEVICE INCLUDING THE SAME SAMSUNG ELECTRONICS CO LTD (KR) 2021-07-22 — — US disclosed
US-20210119148-A1 CONDENSED CYCLIC COMPOUND AND ORGANIC LIGHT-EMITTING DEVICE INCLUDING THE SAME SAMSUNG ELECTRONICS CO LTD (KR) 2021-04-22 — — US disclosed
US-10985329-B2 Condensed cyclic compound and organic light-emitting device including the same SAMSUNG ELECTRONICS CO., LTD. (KR) 2021-04-20 — — US disclosed
US-20190074451-A1 CONDENSED CYCLIC COMPOUND AND ORGANIC LIGHT-EMITTING DEVICE INCLUDING THE SAME SAMSUNG ELECTRONICS CO LTD (KR) 2019-03-07 — — US disclosed
US-20150171340-A1 CONDENSED CYCLIC COMPOUND AND ORGANIC LIGHT-EMITTING DEVICE INCLUDING THE SAME SAMSUNG ELECTRONICS CO., LTD. (KR) 2015-06-18 — — US disclosed
US-20150171340-A1 CONDENSED CYCLIC COMPOUND AND ORGANIC LIGHT-EMITTING DEVICE INCLUDING THE SAME SAMSUNG ELECTRONICS CO., LTD. (KR) 2015-06-18 — — US disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (4 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20210226134-A1 CONDENSED CYCLIC COMPOUND AND ORGANIC LIGHT-EMITTING DEVICE INCLUDING THE SAME CRY1, CCNE2, CRY2 CYP1A2 687/4885MAPT 1656/4885CYP2C9 403/4885
US-10985329-B2 Condensed cyclic compound and organic light-emitting device including the same CRY1, CCNE2, CRY2 CYP1A2 687/4885MAPT 1656/4885CYP2C9 403/4885
US-20210119148-A1 CONDENSED CYCLIC COMPOUND AND ORGANIC LIGHT-EMITTING DEVICE INCLUDING THE SAME CRY1, CCNE2, CRY2 CYP1A2 687/4885MAPT 1656/4885CYP2C9 403/4885
US-20190074451-A1 CONDENSED CYCLIC COMPOUND AND ORGANIC LIGHT-EMITTING DEVICE INCLUDING THE SAME CRY1, CCNE2, CRY2 CYP1A2 687/4885MAPT 1656/4885CYP2C9 403/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.

Send feedback